Study of Pembrolizumab Combined With Decitabine and Pralatrexate in PTCL and CTCL
Clinical trial NCT03240211 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03240211
- Sponsor
- University of Virginia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-02
- Primary completion
- 2025-07-24
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.